Traws Pharma, Inc. (TRAW) Total liabilities 2015–2024
Traws Pharma, Inc. (TRAW) total liabilities at each fiscal year-end, per SEC filings.
$11.2MFY2024 · since FY2015: $18.1M → $11.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $11.2M | -80.1% |
| FY2023 | $56.6M | +371.2% |
| FY2022 | $12.0M | +8.6% |
| FY2021 | $11.1M | +18.2% |
| FY2020 | $9.4M | -32.2% |
| FY2019 | $13.8M | +14.1% |
| FY2018 | $12.1M | -3.5% |
| FY2017 | $12.5M | -20.9% |
| FY2016 | $15.8M | -12.5% |
| FY2015 | $18.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice